Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

The UK’s Royalties withholding tax consultation: Pushing extraterritorial boundaries

April 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Norton Rose Fulbright, feature, pharma, tax consultation

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …
Feature

AZ’s Tagrisso gets FDA nod in first-line EGFR-mutated lung cancer

April 19, 2018 Sales and Marketing AstraZeneca, Cancer, EGFR-TKIs, NSCLC, Tagrisso, lung cancer, pharma

AstraZeneca has announced that its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib) has received approval from …
News

Merck KGaA finds consumer health buyer in P&G for €3.4bn

April 19, 2018 Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical

Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …
News

Immunomedics’ whirlwind in the C-suite continues

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …
Appointment

Frequency Therapeutics hires industry vet

April 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …
Appointment

BMS’ Opdivo+Yervoy combo secures FDA approval in kidney cancer

April 18, 2018 Research and Development, Sales and Marketing BMS, Bristol Myers Swuibb, Cancer, FDA, Yervoy, carcinoma, opdivo, pharma

The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers …
News

EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018 Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …
News

All indications point to approval for cannabis-based therapy

April 17, 2018 Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …
News

FDA flip-flops on Alkermes’ drug application

April 17, 2018 Manufacturing and Production, Sales and Marketing Alkermes, FDA, biotech, drugs, pharma, pharmaceutical

Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the …
News

Amazon puts selling pharmaceuticals plan on back-burner

April 17, 2018 Manufacturing and Production, Sales and Marketing amazon, biotech, drugs, pharma, pharmaceutical, pharmacy

Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …
News

Care packaging: Inside the Falsified Medicines Directive

April 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, packaging, pharma, pharmaceutical

When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …
Feature

Novartis’ Entresto helps preserve kidney function in chronic heart failure patients

April 16, 2018 Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma

Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …
News

Sanofi looks to trim down with divestments

April 16, 2018 Sales and Marketing Charterhouse Capital, Sanofi, Zentiva, biotech, drugs, pharma, pharmaceutical

Sanofi has begun part of a larger process of slimming down its business with the sales of 12 medicines. It …
News

J&J’s ketamine nasal spray for depression continues to impress

April 16, 2018 Research and Development, Sales and Marketing Johnson & Johnson, Ketamine, biotech, drugs, pharma, pharmaceutical

New treatments for depression are few and far between; pharmaceutical companies have shied away from trying to develop new therapeutics …
News

Keytruda continues success with new Phase 3 data in adjuvant melanoma

April 16, 2018 Research and Development, Sales and Marketing Cancer, MSD, keytruda, melanoma, pharma, skinc cancer

MSD has revealed new efficacy data for Keytruda (permbrolizumab) as an adjuvant therapy in the treatment of resected, high-risk stage …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026